Spot stenting versus full coverage stenting after endovascular therapy for femoropopliteal artery lesions.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
10 2019
Historique:
received: 13 06 2018
accepted: 22 12 2018
pubmed: 10 3 2019
medline: 26 5 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

Although spot stenting (SS) for femoropopliteal (FP) lesions has been preferred compared with full coverage stenting (FCS), which stenting strategy results in better outcomes has remained unclear in the real-world clinical setting. Therefore, we compared the clinical outcomes of SS and FCS for FP lesions using a propensity-matched analysis. The present multicenter, retrospective study examined data from a clinical database of 1554 consecutive patients who had undergone FP endovascular therapy for symptomatic peripheral artery disease from January 2010 to December 2016. Of these patients, 1151 had undergone FP stenting. The outcome measures were primary patency and primary assisted patency obtained using propensity score matching. Interaction analysis was also performed to explore the effects of the baseline characteristics on the association between SS and primary patency. After propensity score matching, SS for FP lesions demonstrated a significantly lower primary patency rate compared with FCS at 3 years (29% vs 53%; P = .011). Additionally, primary assisted patency at 3 years was significantly lower in the group with SS than in the FCS group (53% vs 72%; P = .014). Interaction analysis showed that chronic total occlusion lesions, lesion location A (proximal superficial femoral artery portion), and lesion length ≥138 mm were associated with the noninferiority of SS compared with FCS for primary patency. The propensity-matched analysis demonstrated that primary patency and primary assisted patency at 3 years were significantly lower with SS compared with FCS for FP lesions in real-world clinical settings. The interaction analysis suggested that SS might be suited to more complex FP lesions (ie, chronic total occlusion lesions, proximal superficial femoral artery lesion, lesion length ≥138 mm).

Identifiants

pubmed: 30850285
pii: S0741-5214(19)30188-0
doi: 10.1016/j.jvs.2018.12.044
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1166-1176

Informations de copyright

Copyright © 2019 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Yusuke Tomoi (Y)

Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan. Electronic address: mbxtg263@ybb.ne.jp.

Yoshimitsu Soga (Y)

Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.

Mitsuyoshi Takahara (M)

Department of Diabetes Care Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.

Masahiko Fujihara (M)

Department of Cardiology, Kishiwada Tokushukai Hospital, Kishiwada, Japan.

Osamu Iida (O)

Department of Cardiology, Kansai Rosai Hospital, Amagasaki, Japan.

Daizo Kawasaki (D)

Cardiovascular Division, Morinomiya Hospital, Morinomiya, Japan.

Kenji Ando (K)

Department of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH